More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Deflazacort [14484-47-0]

Deflazacort [14484-47-0]

Research Use Only
D1624
LKT Laboratories
Estimated Purity≥98%
Product group Chemicals
€ 273,00
250 mg
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    LKT Laboratories
  • Product Name
    Deflazacort [14484-47-0]
  • Delivery Days Customer
    7
  • Certification
    Research Use Only
  • Estimated Purity
    ≥98%
  • Scientific Description
    Oxazoline; glucocorticoid agonist.
  • Storage Instruction
    Ambient
  • UNSPSC
    12352200

References

  • Hoffman EP, Reeves E, Damsker J, et al. Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am. 2012 Nov;23(4):821-8. PMID: 23137739. Silva EC, Machado DL, Resende MB, et al. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2012 Mar;70(3):191-5. PMID: 22392111. Joshi N, Rajeshwari K. Deflazacort. J Postgrad Med. 2009 Oct-Dec;55(4):296-300. PMID: 20083885. Marques MJ, Oggiam DS, Barbin IC, et al. Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice. Muscle Nerve. 2009 Sep;40(3):466-8. PMID: 19623634.